CSIMarket
 


Longeveron Inc   (LGVN)
Other Ticker:  
 

Cumulative Longeveron Inc 's Working Capital Ratio for Trailing Twelve Months Period

LGVN's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

LGVN Working Capital Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 164.98 % 117.82 % - - -
Y / Y Current Assets Growth 18.16 % 27.71 % - - -
Working Capital Ratio for Trailing Twelve Months Period 9.97 12.01 14.28 14.74 13.64
Total Ranking # 407 # 502 # 483 # 506 #
Seq. Current Liabilities Growth 2.68 % 50.75 % 10.55 % 54.85 % -15.59 %
Seq. Current Assets Growth -17.71 % -11.39 % -9.93 % 79.91 % -11.06 %


Working Capital Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to rise in Current Liabilities in the III. Quarter to $4 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 9.97 below Longeveron Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 154 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Longeveron Inc . While Working Capital Ratio for Trailing Twelve Months Period overall ranking has improved so far to 407, from total ranking in previous quarter at 502.

What is Working Capital Ratio?
More about LGVN
Working Capital Ratio LGVN in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 155
Sector # 251
S&P 500 # 407


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
11.82 10.99 9.54
(Mar 31 2022)   (Sep 30 2022)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Working Capital Ratio for Trailing Twelve Months Period
Edgewise Therapeutics inc.  26.97 
Merrimack Pharmaceuticals Inc  26.97 
Spruce Biosciences Inc   26.94 
Janux Therapeutics Inc   26.91 
Karuna Therapeutics Inc   26.74 
Pmv Pharmaceuticals Inc   26.51 
Immuneering Corp  26.41 
Gemini Therapeutics Inc   26.21 
Dice Therapeutics Inc   25.72 
Anaptysbio inc  25.17 
Olema Pharmaceuticals inc   24.94 
Cyteir Therapeutics Inc   24.67 
Cassava Sciences Inc   24.63 
Silverback Therapeutics Inc   24.38 
Kura Oncology Inc   23.87 
Imago Biosciences Inc   23.87 
Sensei Biotherapeutics Inc   23.62 
Astria Therapeutics inc   23.42 
Kalvista Pharmaceuticals Inc.  23.32 
Agios Pharmaceuticals Inc   23.32 
Eliem Therapeutics Inc   23.23 
Anixa Biosciences Inc   22.83 
Oramed Pharmaceuticals Inc   22.36 
Rani Therapeutics Holdings Inc   22.06 
Arena Pharmaceuticals Inc   21.88 
Kinnate Biopharma Inc   21.17 
Generation Bio Co   21.16 
Pardes Biosciences Inc   20.85 
Rallybio Corporation  20.84 
Nkarta Inc   20.57 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PT's Profile

Stock Price

PT's Financials

Business Description

Fundamentals

Charts & Quotes

PT's News

Suppliers

PT's Competitors

Customers & Markets

Economic Indicators

PT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071